NASDAQ NMS - GLOBAL MARKET · BFRI
+1.35% · +$0.0200 · Vol Not reported
Pre-market · updated 04:00:25 ET
Biofrontera Inc

Biofrontera Inc

Pharmaceuticals
$1.50
Card
Relationship Map

Veridion Score

BETALOW CONF · 6/6 factorsMethodology
BFRI
Biofrontera Inc
Fri Aug 21 · last completed session · Pre-market · regular session opens 9:30 ET
NEUTRAL

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

59/ 100
Veridion Score
NEUTRAL · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 6/6 factors with data · Fri Aug 21 · last completed session · Pre-market · regular session opens 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is BFRI moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading BFRI catalysts
About Biofrontera Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2021
Employees
94
Country
US

Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$1.48
Last session
Day high
$1.48
Last session
Day low
$1.48
Last session
Previous close
$1.48
52W high
$1.50
0.00% from high
52W low
$0.5700
100% of range
Market cap
$22M
EPS
$-1.5500
Beta
1.64
Shares out
14.9M
Avg volume
448.2K
VWAP
$1.48
Last session
Price history computed in-house
1W
+11.11%
1M
+37.61%
3M
+88.68%
1Y
+55.65%
YTD
+163.16%
SMA 50 $1.13 · above
SMA 200 $0.9541 · above
52W position 100%

BFRI overview

Veridion Score
59
Registered · 2026-08-21
6 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around BFRI.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading BFRI Form 4 filings
Public disclosures

Congress activity in BFRI

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for BFRI in the cached public ledger.

Federal contracts

BFRI contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for BFRI in this window.
Lobbying spend

BFRI lobbying filings, year to date.

Registered lobbying filings matched to Biofrontera Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for BFRI in this window.
Loading news for BFRI
Analyst ratings
Sovereign unlock shows live analyst consensus for BFRI.
Options
Sovereign unlock shows live options positioning for BFRI.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.